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Background: Recent conﬂicts in Afghanistan and Iraq produced a substantial number of critically wounded
service-members. We collected biomarker and clinical information from 73 patients who sustained 116 life-
threatening combat wounds, and sought to determine if the data could be used to predict the likelihood of
wound failure.
Methods: From each patient, we collected clinical information, serum, wound efﬂuent, and tissue prior to and at
each surgical débridement. Inﬂammatory cytokineswere quantiﬁed in both the serumand efﬂuent, aswere gene
expression targets. The primary outcomewas successful wound healing. Computer intensivemethodswere used
to derive prognosticmodels thatwere internally validated using target shufﬂing and cross-validationmethods. A
second cohort of eighteen critically injured civilian patients was evaluated to determine if similar inﬂammatory
responses were observed.
Findings: The best-performing models enhanced clinical observation with biomarker data from the serum and
wound efﬂuent, an indicator that systemic inﬂammatory conditions contribute to local wound failure. A Random
Forestmodel containing ten variables demonstrated the highest accuracy (AUC0.79). Decision Curve Analysis in-
dicated that the use of this model would improve clinical outcomes and reduce unnecessary surgical procedures.
Civilian trauma patients demonstrated similar inﬂammatory responses and an equivalent wound failure rate,
indicating that the model may be generalizable to civilian settings.
Interpretation: Using advanced analytics, we successfully codiﬁed clinical and biomarker data from combat
patients into a potentially generalizable decision support tool. Analysis of inﬂammatory data from critically ill
patients with acute injurymay inform decision-making to improve clinical outcomes and reduce healthcare costs.
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During the last decade of conﬂict in Afghanistan and Iraq, our
military health system (MHS) treated a large number of critically-
wounded servicemen and women (Casualty Report). Many of them
sustained systemic polytrauma, mangled extremities and traumatic
amputations from blasts. These devastating injuries pushed the physio-
logic reserves of these generally young, previously healthy patients to
the extreme. Thanks to the combined effects of body armor, tourniquets,
tactical combat casualty care, aggressive resuscitation techniques, and a
robust trauma system, many service members who would have died in
previous conﬂicts survived to reach tertiary care facilities (Elster et al.,
2013; Sheridan et al., 2014). Because these survivors posed substantial
reconstruction and rehabilitation challenges, we organized a coordinat-
ed effort to characterize the physiologic response of military patients to
these devastating injuries, and determine if particular biomarkers
predict perioperative complications.
Early in the conﬂicts, we noted that severely-injured patients
demonstrate systemic inﬂammatory dysregulation and relative immu-
nosuppression (Hawksworth et al., 2009). This suggests that the native
inﬂammatory system, geared toward mitigating less severe injuries, is
ill-equipped to regulate the massive physiologic insults produced by
blast injuries (Hawksworth et al., 2009). Complications such as delayed
wound healing and dehiscence (Forsberg et al., 2008), venous thrombo-
embolism (Gillern et al., 2011), and ventilator-associated pneumonia
(Landrum andMurray, 2008) occurredmore frequently than expected;
and unanticipated outcomes such as heterotopic ossiﬁcation (Potter
et al., 2007; Forsberg et al., 2009) and angioinvasive fungal infections
(Warkentien et al., 2012) were frequently observed. In fact, even highly
experienced military surgeons had difﬁculty risk-stratifying their
patients' wounds (Forsberg et al., 2014) because the conventional
manner of visually assessing wounds (Bartlett, 2003; Stromeyer, 1862;
Moorhead, 1942a; Selcer, 2008) was inadequate.
The timing of wound closure is important. If a combat wound is
closed prematurely, it is more likely to dehisce. When this happens,
the injured service member requires additional surgical procedures
that can jeopardize life, limb or residual limb length. However, if a
wound is closed unnecessarily late, the delay and additional procedures
prolong the patient's hospital stay, delay rehabilitation, and increase the
risk that the patient will develop a hospital-acquired infection or other
complication. In the hopes of optimizing care, we sought to characterize
each patient's physiologic response to injury, with the goal of develop-
ing a decision support tool to guide the timing of wound closure.
2. Materials and Methods
2.1. Selection of Patients
Study participants were screened and treated at Walter Reed
National Military Medical Center (WRNMMC), Bethesda, MD, between
January 2007 and January 2012. Each candidate participant had been
evacuated from Iraq or Afghanistan after sustaining a combat-related
injury to one or more extremities. All had at least one extremity
wound N75 cm2 treated en route with negative pressure wound
therapy.
To get a preliminary sense of the validity and generalizability of our
ﬁndings, we also enrolled a civilian comparison group of patients who
were treated in theMarcus Trauma Center of Grady Memorial Hospital,
a civilian Level I trauma center in Atlanta, GA. Both groups, military and
civilians, were enrolled using a common IRB approved study protocol.
2.2. Human Subject Considerations
Inclusion criteria for this study as at least one extremity wound
N75 cm2 treated with negative pressure wound therapy withoutimmune or connective tissue disorders. Details of the consenting
process are outlined below.
2.3.Walter Reed National Military Medical Center (Study Number 352334)
This study was reviewed and approved by theWalter Reed National
Military Medical Center Institutional Review Board. We consider com-
bat casualties to be a vulnerable patient population. Because of this,
every effort was made to eliminate the appearance of military rank,
authority, or the perception of coercion during the enrollment process.
Patients were identiﬁed by the manifest of incoming combat casualties
from overseas. Each prospective study participant received a standard-
ized brieﬁng by one of three research associates speciﬁcally trained in
the informed consent process. Informed consent was obtained for
each study participant. For those who were unconscious, or otherwise
unable to communicate, we obtained informed consent from the
patient's legally authorized representative in accordance with local
and federal regulations. Patients enrolled by this method were re-
consented after their cognitive status improved, after ﬁrst being given
the opportunity to withdraw from the study. Each study participant
was given the opportunity to withdraw from the study at regular
intervals, coinciding with the timing of sample collection.
2.4. Grady Memorial Hospital (Study Number 00058229)
This study was reviewed and approved by the Emory University
Institutional Review Board and the Grady Hospital Research Oversight
Committee. Patients were identiﬁed by one of the co-investigators
during attendance at general surgery morning reports, attendance of
trauma bay resuscitations, review of surgical operative logs and refer-
rals from other admitting surgeons. Other admitting surgeons were
contacted to ensure they are in agreement with patient enrollment
prior to approach of the patient. Patients were informed that they
could withdraw from the study at any time and for any reason without
penalty or adjustments in their routine care. All patients with wounds
that met inclusion criteria were approached by study personnel and
the patient and/or the patient's family were engaged in a detailed dis-
cussion about the aims of the study and the potential risks and beneﬁts
of study participation. Potential subjects were also informed that
wounds seen in the civilian setting would be analyzed and compared
to similar ﬁndings in military patients with war wounds. For patient's
unable to give personal consent for this study, the next-of-kin or legally
authorized representative were approached and consent sought after
appropriate discussion as described.
Any candidate study participant found to have a confounding co-
morbid condition, such as an immune or connective tissue disorder,
was excluded. To guide the timing of closure, surgeons at both used
the conventional “4C's”: color, consistency, contractility when stimulat-
ed, and the capacity to bleed when incised (Bartlett, 2003; Bowyer,
2006).
2.5. Demographics
We collected a comprehensive set of demographic and clinical
information, including gender, age, body mass index (BMI), tobacco
use, mechanism of injury, Injury Severity Score (ISS), time from injury,
units of transfused blood products, and associated neurovascular or
traumatic brain injuries. At the time of each surgical débridement, we
also recorded the patient's APACHE II score, wound size, and time
from injury. Each wound was followed for a minimum of six weeks
following surgical closure. Successful closure was deﬁned as greater
than 90% split thickness skin graft acceptance, the absence of infection
(Sherertz et al., 1992), and the absence of dehiscence following delayed
primary closure. Dehiscence was deﬁned as a reopened wound that
required additional surgical treatment within 30 days of closure or
coverage.
Table 1
Patient demographics and wounds reﬂective of the military patient population.
Number (%) or median (IQR)
Patients (n = 73)
Age (years) 22 (18.26)
Gender
Male 73 (100)
Injury Severity Score 16 (4,28)
Traumatic brain injury
Yes 47 (64.4)
No 20 (27.4)
Unknown 6 (8.2)
Hospital length of stay (days) 26 (4,48)
ICU length of stay (days), 32 patients 3 (1,7.5)
Number of wounds
1 38 (52.1)
2 27 (37)
3 8 (11)
Wounds (n = 116)
Mechanism of Injury
Blast 106 (91.4)
Crush 1 (0.9)
GSW 9 (7.8)
Wound location
Lower Extremity 97 (83.6)
Upper Extremity 19 (16.4)
Wound surface area (cm2) 225 (43,407)
Wound type
Amputation 15 (12.9)
Lower extremity 12 (10.3)
Upper extremity 3 (2.6)
Fasciotomy 24 (20.7)
Lower extremity 21 (18.1)
Upper extremity 3 (2.6)
Open fracture 12 (10.3)
Lower extremity 9 (7.8)
Upper extremity 3 (2.6)
Traumatic soft tissue injury 65 (56)
Lower extremity 55 (47.4)
Upper extremity 10 (8.6)
Injury to closure (days) 10 (5.75,14.25)
Hospital arrival to closure (days) 5 (1,9)
Wound failure
Dehisced 27 (23.3)
Healed 89 (76.7)
1237J.A. Forsberg et al. / EBioMedicine 2 (2015) 1235–12422.6. Sample Collection
Serum andwound efﬂuent sampleswere collected at the time of each
débridement procedure, which occurred approximately every 48–72 h
until wound closure or coverage was performed (Hawksworth et al.,
2009). Up to three wounds per patient were monitored.
After each débridement, a representative tissue biopsy was taken
from the central portion of each wound. For transcript analysis, an ali-
quot (30–35mg)was used for RNA extraction, whichwas subsequently
validated using spectroscopic (NanoDrop) and gel-electrophoretic
(Agilent Bioanalyzer 2100) techniques prior to being converted to com-
plementary DNA (cDNA).
2.7. Gene Transcript Analysis
Wound biopsies were analyzed for 190 inﬂammatory and wound
healing genes. RNA extracted from each biopsy was required to exhibit
an A260/A280 ratio ≥1.6, an RNA Integrity Number ≥8, and an 18S/16S
rRNA peak ratio ≥1.7. Qualiﬁcation of cDNA was achieved using real-
time qPCR targeting 18S (required CT in the range 7–10 using a threshold
of 0.1). Qualiﬁed cDNA samples were loaded to a low-density array
(Applied Biosystems) containing target speciﬁc primers and probe. A
maximum CT of 35 cycles was used and individual gene transcript
expressions were normalized to 18S rRNA. Relative quantitation was
evaluated using the 2−ΔΔCt method (Livak and Schmittgen, 2001).
At theﬁnal débridement, the qPCR datawas evaluated by generating
an Ingenuity iReport for Isoform-level Human RNA-Sequence Data
(IPA®, QIAGEN Redwood City, California, USA). For these analyses, we
used a threshold p-value of 0.05 and fold change of 1.5. The endogenous
controls were MAPK14, NFKB1, TGFBR1, 18 s, and GAPDH; the 18 s had
score of 0.87 and GAPDH 1.158 as described by Vandesompele et al.
(Vandesompele et al., 2002).
2.8. Protein Analysis
Serum and wound efﬂuent proteins were quantiﬁed using a Luminex
100/200 IS xMAP Bead Array Platform (Millipore Corp, Billerica, MA) as
previously described (Hawksworth et al., 2009). Thirty-two cytokines,
chemokines and growth factors were quantiﬁed using a Human Cytokine
30-plex panel supplemented with a custom Human 2-plex panel (Life
Technologies; Cat. No LHC6003 and LCP0002, Grand Island, NY). Data
were categorized as related to the initial débridement, the penultimate
débridement, and the ﬁnal débridement.
2.9. Statistics, Data Modeling, and Cost Analysis
Both parametric statistical and machine learning methodologies
(BayesianBelief Networks— BBN; RandomForest Analysis—RF; logistic
regression using Least Absolute Shrinkage and Selection Operator —
LASSO) were used to analyze the data. The goal was to estimate the
likelihood of wound failure, while incorporating target shufﬂing, cross
validation, and decision analysis. Additionally, a cost-savings analysis,
for both civilian and military health systems, was also developed.
We performed univariate analysis to identify general relationships
between wound outcome and serum, efﬂuent and gene expression
targets. Statistical differences between these continuous variables and
wound outcome were evaluated using the Mann–Whitney U test and
the post hoc Tukey–Kramer assessment. The levels of signiﬁcance
were adjusted using the false discovery rate method.
We then performed logistic regression using LASSO, and machine
learning using RF and BBN modeling techniques. Two RF models were
created; one that evaluated all features, and one that contained only
the top 10 features after ranking variable importance using a RF ﬁlter.
The goal was to develop models designed to estimate the likelihood of
healing for an individual wound, based on clinical, systemic and local-
ized wound information contained within each record. With 157variables and 27 events (failed wounds), we mitigated the risk of
overﬁtting the ﬁnal model to the training set using 10-fold cross valida-
tion, aswell as by a variety ofmethods unique to eachmodeling process.
For the BBN, a proprietarymachine-learning algorithm (FasterAnalytics,
DecisionQ Inc., Washington DC, USA) uses a scoring formula that bal-
ances goodness of ﬁt against robustness using a parsimony metric. The
RF models employ the random subspace method (Ho, 1998) and the
LASSO method (Tibshirani, 1997) inherently minimizes overﬁtting
through L1 regularization, via penalization of the loss function.
In order to ensure the relationships identiﬁed by each modeling
technique were not due to chance alone, we used a target shufﬂing
technique (Nisbet et al., 2009). Brieﬂy, we compared each model built
with the original training data against a permuted null distribution con-
taining 1000 iterations with the wound outcomes (healed or dehisced)
shufﬂed randomly among each of the records. Iterated cross-validation
was used to evaluate the likelihood of sample bias resulting from a sin-
gle round of k-fold cross-validation. For each model, the mean area
under the curve (AUC) of the receiver operator characteristic (ROC)
curves for all 1000 iterations was reported.
The methodology used to develop, validate, and update these
models conforms to the Transparent Reporting of multivariable predic-
tion model for Individual Prognosis Or Diagnosis (TRIPOD) guidelines.
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We ﬁrst assessed accuracy using 10-fold Cross-validation. The data
were randomized into 10 matching train-and-test sets. Each training
set comprised 90% of records and model development to include vari-
able and coefﬁcient selection were performed on each unique training
set. A corresponding test set comprised the remaining 10% of records.
Eachmatching setwas unique to ensure therewas nooverlapping infor-
mation between sets. I.e. Each test set contained true unknowns, and
none of the information comprising the test set was used to develop
the corresponding models.
Formost surgical problems, the consequences of undertreatment are
generally less desirable than those associated with overtreatment.
Decision Curve Analysis (DCA) (Vickers and Elkin, 2006) allows one to
evaluate model performance by weighing the relative consequences of
a falsely positive or negative result. This technique allows one not
only to compare a variety of classiﬁers directly, but is also critical
prior to recommending the model(s) be used clinically. We used
FasterAnalytics™ (DecisionQ,Washington, DC, USA) for the BBNmodel-
ing, and R© Version 3.0 (R Core Team) for all other data processing,
curation and analysis.
2.11. Economic Impact Analysis
We estimated cost savings that might be gained through implemen-
tation of this clinical decision support tool across the US healthcare
system. In doing so, we conducted an extensive medical and publicFig. 1. This Ingenuity functional map depicts 23 genes differentially expressed in thpolicy literature review of over 200 peer-reviewed papers. We focused
on those papers that provided insight into the care of open wounds as-
sociated with trauma and an inpatient hospital stay. The content was
drawn from the National Center for Biotechnology Information's
PubMed Central® databases and U.S. Library of Congress. In addition,
we obtained healthcare outcome data, such as the number of relevant
medical cases in North America, Western Europe, and Australia. More-
over, since open wounds can be associated with a very large variety of
medical conditions, we focused on those that speciﬁcally required
some level of critical care. The cost savings associated with Hospital Ac-
quired Infectionswas also determined as a function of hospital length of
stay (HLOS). Extending our analysis to the Department of Defense's
Military Health System (MHS), we retroactively applied our national
cost-savings ﬁgures to patientswith extremity injuries sustained during
Operation Iraqi Freedom and Operation Enduring Freedom (population
data provided by the US Army Institute of Surgical Research — Joint
Theater Trauma Registry). Cost-savings associated with a reduction in
operating room visits were also factored into our model.2.12. Role of the Funding Source
Funding was provided by the United States Department of Defense
Health Programs. JAF, BKP and EAE are active duty service members
and performed this work as part of their ofﬁcial duties. All authors had
complete access to all of the data and had responsibility for the decision
to submit for publication.e 19 wounds that failed, compared to those that went on to heal uneventfully.
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3.1. Combat-wounded Patients Require Signiﬁcant Resources
During the study period, 410 consecutive injured service mem-
bers were screened for enrollment. Of these, 75met inclusion criteria
and provided informed consent. After enrollment, one participant
requested to be withdrawn from the study, and one was lost to
follow-up. This left 73 participants with 116 unique wounds who
underwent 399 individual débridements. The majority of our
subjects were injured by blasts from improvised explosive devices;
the vast majority had an Injury Severity Score of 16 (Interquartile
Range IQR 4,28), and most required a lengthy hospital stay, withFig. 2. The Bayesian Belief Network can be represented graphically, as demonstrated in Panel
Panels B and C, respectively.about one in four staying longer than 7 weeks. Twenty-three percent
of wounds failed after initial closure. The demographic proﬁle of
enrollees is summarized in Table 1.
3.2. Systemic Responses Appear to be a key Driver of Outcome
An analysis of systemic and local cytokines and chemokines suggest
that failed wound closure was associated with substantial systemic in-
ﬂammation. Univariate comparisons demonstrated that serum IL-7,
RANTES, VEGF, IFN-γ, IL-10, EOTAXIN, MCP-1, IL-6, IL-2R, HGF, IL-2,
IL-17 and EGF and the Efﬂuent IL-7, IL-6, IFN-γ, IL-2R, IL-4, and IP-10
differed signiﬁcantly (adjusted p b 0.05) in wounds that ultimately
failed, compared to those that healed uneventfully. Thirteen of theseA. Receiver Operator Characteristic Analysis and Decision Curve Analysis are depicted in
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inﬂammatory response to injury.
3.3. The Local Wound Environment Contributes to Wound Failure
Univariate analysis of thewound gene expression data demonstrated
twenty-three transcripts that were differentially expressed in the
wounds that failed, compared to those that healed uneventfully. These
transcripts are predominately involved in cell migration, leukocyte
recruitment, and regulation of the immune response. Fig. 1 depicts
these genes, grouped by molecular function.
3.4. Mathematical Modeling Produced Clinically Promising Decision
Support Tools
Each modeling method yielded prognostic information. The BBN,
represented graphically (Fig. 2a), revealed seven features that are
most closely related to the wound outcome, Serum IL7, Efﬂuent IL4,
Serum IL1a, Serum MCP-1, Efﬂuent IL-6, Genitourinary trauma, and
the transfusion requirement after admission. After measuring accuracy
(Fig. 2b), the RF model designed to select the 10 important features
was most accurate (AUC 0.79; 95% C.I. 0.57–0.91) followed by the BBN
(12 features) (AUC 0.74; 95% C.I. 0.53–0.90) and the RF model designed
to consider all 157 features contained within each record (AUC 0.72;
95% C.I. 0.47–0.83). The LASSOmodel (AUC 0.62; 95% C.I. 0.53–0.8) per-
formed worst of all models and required 8 variables. Throughout the
modeling process, we sought tomitigate the risk of overﬁtting whenev-
er possible. Our efforts to do so are described in the Statistics, Data
Modeling, and Cost Analysis section, above.Fig. 3. The comparison of inﬂammatorymediators in the serum and efﬂuent ofmilitary and civil
the concentrations of these proteins in the military patients.All models demonstrated positive net beneﬁt, indicating they are
preferable to assuming that all patients or no patients undergo wound
closure (Fig. 2c) at the penultimate débridement. The BBN and RF
models were associated with the highest net beneﬁt at some point
along the curve, indicating that either could be used clinically, depend-
ing on the surgeon's threshold probability—the point at which he or she
would become indecisive about whether to close a particular wound.
However, the RF model with 10 features provided the highest net ben-
eﬁt over the broadest range of threshold probabilities, indicating that it
may be best for clinical use. These results suggest if the only wounds
closed were those with a less than a 25% risk of failure, out of every
100 patients, 88woundswould be closed sooner, 12woundswould un-
dergo additional débridement(s) prior to closure, and therewould be 12
fewer wound failures than if surgeons used standard practice.
3.5. Lessons Learned from Military Trauma Apply to Civilians
To determine if the biologic responses seen in our military cohort
apply to civilian trauma patients, we analyzed a second set of 18 sub-
jects with 27 signiﬁcant extremity wounds who underwent 49 surgical
débridements. Most of these injuries were due to blunt trauma; none
were related to blast. Four (15%) of the closedwounds failed. Of note, ci-
vilian patients with wound failure exhibit similar distributions in HLOS
as those derived from our military sample. Fig. 3 depicts the similarities
between the concentrations of the majority of serum and efﬂuent
biomarkers in military and civilian patients (Fig. 3). Due to differences
in sample analysis platform, direct external model validation was not
possible; however, these preliminary ﬁndings suggest that future
validation of our existing model using civilian patients will be feasible
and such tools will be relevant for both populations.ian patients demonstrates similar distributions.We observedmore variability, however, in
1241J.A. Forsberg et al. / EBioMedicine 2 (2015) 1235–12424. Discussion
Blast injuries and other combat-associated wounds present unique
challenges to healthcare providers and institutions.We found that com-
prehensive biological assessment, coupledwith advancedmathematical
techniques, can be used to generate predictive models that may help
surgeons minimize wound-related complications, decrease hospital
lengths of stay and lower costs.
For this study, we used demographic, injury, clinical, proteomic,
transcriptomic information and machine learning techniques to
estimate the likelihood of wound failure in 73 severely injured combat
casualties. We did this by using a set of individually low sensitivity/low
speciﬁcity biomarkers coupled with clinical data to create high sensitiv-
ity/high speciﬁcity estimations that can inform surgeons when to close
wounds to maximize the likelihood of healing and minimize the risk of
dehiscence. Improving medical decision-making and critical care in this
manner offers several potential beneﬁts (Chen et al., 2013), including
minimizing complications, improving outcomes, accelerating recovery
and reducing costs. Moreover, our ﬁndings suggest that our observations
may be generalized to civilian injuries (Biddinger et al., 2013).
Although our ﬁndings are promising, this study has limitations. Blast
wounds produce highly diverse injury patterns, and ourmilitary patient
population is comprised of young, previously healthy individuals. It is
possible that models generated using data from these patients may
not apply to older individuals or patients who have sustained other
types of trauma. Our ﬁnding that a relatively small sample of civilian
trauma patients mounts similar physiologic responses to injury sug-
gests our approach may be applicable outside military populations,
but this must be veriﬁed in larger samples of patients. Even moreFig. 4. Cost analysis over the US healthcare system suggests that the use of this clinical decision
system, by reducing ICU, general ward, and rehabilitation stays by 1.7, 2.1, and 4.2 days respecimportant, our study is limited by its relatively small sample size,
which can be troublesome considering the large number of variables
analyzed in each record. In such situations, it can be difﬁcult to detect
meaningful patterns in the data, which also increases the risk of
overﬁtting the models and producing overly optimistic measures of
accuracy. By reducing the features in themodel usingmachine learning
to identify relevant features, and randomizing the training data using
target shufﬂing (Nisbet et al., 2009), we decreased the risk of overﬁtting
and helped ensure the patterns detected by each modeling approach
were unlikely to be due to chance. An additional concern is that
wound failure was unequally distributed throughout the dataset.
Given the relatively small number of failedwounds, it is statistically eas-
ier to identify patterns associated with normal wound healing than less
common outcomes such as wound failure. Despite these concerns, we
achieved our goal of developing models to estimate the likelihood of
wound failure.
Past contributions of military medicine to civilian health care are
numerous and substantive. They include improvements in ground and
aeromedical medical evacuation (Larrey, 1814; Connor, 2010), regula-
tion (Anon., 1937), open treatment of severe wounds (Moorhead,
1942a, 1942b; Gould, 1917), the combination of surgical débridement
with local and systemic use of antibiotics to reduce surgical site
infection and sepsis (Moorhead, 1942a, 1942b; Meleney, 1948;
Neushul, 1993), the application of vascular surgical techniques (Rich
and Hughes, 1969), and, more recently, renewed use of tourniquets
and other modalities to achieve ﬁeld hemostasis (Lakstein et al., 2003).
Each of these advances was catalyzed by one or more armed conﬂicts
that stimulated quantum improvements in the treatment of severely in-
jured patients. Most of these medical advances are now ubiquitous insupport tool may afford yearly savings of $1.09B (£730 million) across the US Healthcare
tively.
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becoming so (Biddinger et al., 2013).
Efforts to apply advanced analytics to support clinical decision
making have the potential to transform healthcare, as dramatically as
advanced analytics have transformed the ﬁnancial, manufacturing,
logistics and telecommunications industries (Brown et al., 2011). In
addition to reducing lengths of stay and therefore inpatient costs, preci-
sion medicine can improve patient outcomes and save lives. Increasing
the efﬁciency may be particularly important in ICUs, which represent
only 10% of inpatient beds, but 20–35% of hospital operating costs
(Krell, 2010).
We are not the ﬁrst group to attempt to apply knowledge gained in
armed conﬂict to beneﬁt future trauma victims. For example, the prac-
tice of quantitative bacterial cultures gained popularity after animal
studies demonstrated the deleterious effects of high bacterial counts
on split thickness skin graft healing (Liedberg et al., 1955). The tech-
nique was further developed for use in blast and burn wounds during
the Vietnam era to estimate the likelihood of wound healing (Robson
and Heggers, 1969; Krizek and Robson, 1975). Though the technique
was successfully translated to the civilian setting in the treatment of
burns, the use of quantitative culturing to predict the clinical course of
blast wounds was lost. By reafﬁrming this observation that clinical
decisions can be guided by biologic data in traumapatients, and demon-
strating its utility in a preliminary sample of civilian traumapatients,we
seek to reintroduce civilian practitioners to the value of this approach
using modern assays and analytical capabilities.
If the clinical decision support models we describe perform equally
well in larger samples of patients, they may reduce the rate of open
wound dehiscence to 5%. It this were accomplished, it would represent
a 68% improvement over current practice in the US (Hostetler et al.,
2006). In order to gauge the economic impact of improved decision
making in critically injured patients, we performed an analysis on cost
savings from reduced need for inpatient ICU care, general ward care,
outpatient rehabilitation, and reduced exposure to hospital-acquired in-
fections. Considering the 67,486 patients with traumatic extremity
wounds, our approach could save the US healthcare system approxi-
mately $1 billion (£670 million) per year, primarily by reducing ICU,
general ward, and rehabilitation stays by 1.7, 2.1, and 4.2 days respec-
tively (Fig. 4). Additionally, if the data we report had been available
during the past decade of conﬂict, this approach we describe could
decrease treatment costs in the military health system by more than
$470 million (£314 million).
In summary, this study demonstrates that it is not merely the phys-
ical destructive nature related to the mechanism of injury in wounds,
but the resulting inﬂammatory response that dictates wound outcome.
In addition, by combining biomarker data with clinical observations, we
were able to generate highly predictive algorithms to help surgeons
identify when to close or otherwise cover wounds in high risk military
and civilian populations. Doing so mayminimize the risk of wound fail-
ure and maximize the likelihood of uneventful healing. If further vali-
dated, consistently applying this approach would improve surgical
outcomes, allow trauma patients to spend less time in intensive care,
and reduce healthcare costs.
Acknowledgments
We thank Stacia Moreno, Fred Gage and Felipe Lisboa for coordinat-
ing study enrollment and sample processing. We also thank Richard
Barth, BS and Trevor Brown, PhD for helpful data assembly, Ms. Eliza-
beth Silvius for data analysis, as well as Felix Chang, MBA and Arnaud
Belard, MBA for performing the civilian and military business case
analyses.
References
Anon, 1937. When to lock the stable. N. Engl. J. Med. 217, 960.Bartlett, C.S., 2003. Clinical update: gunshot wound ballistics. Clin. Orthop. Relat. Res.
28–57.
Biddinger, P.D., Baggish, A., Harrington, L., et al., 2013. Be prepared—the BostonMarathon
and mass-casualty events. N. Engl. J. Med. 368, 1958–1960.
Bowyer, G., 2006. Débridement of extremity war wounds. J. Am. Acad. Orthop. Surg. 14,
S52–S56.
Brown, B., Chui, M., Manyika, J., 2011. Are you ready for the era of ‘big data’. McKinsey Q.
http://www.mckinsey.com/insights/strategy/are_you_ready_for_the_era_of_big_
data (October: 1–12).
Casualty Report, d. Casualty Report Casualty Report, http://www.defense.gov/news/
casualty.pdf (accessed Nov 3, 2014).
Chen, L.M., Kennedy, E.H., Sales, A., Hofer, T.P., 2013. Use of health IT for higher-value
critical care. N. Engl. J. Med. 368, 594–597.
Connor, R., 2010. Medevac from Luzon. Air & Space Magazine Smithsonian (published
online July 1).
Elster, E.A., Butler, F.K., Rasmussen, T.E., 2013. Implications of combat casualty care for
mass casualty events. JAMA 310, 475–476.
Forsberg, J., Elster, E., Andersen, R., et al., 2008. Correlation of procalcitonin and cytokine
expression with dehiscence of wartime extremity wounds. 90, 580–588.
Forsberg, J.A., Pepek, J.M., Wagner, S., et al., 2009. Heterotopic ossiﬁcation in high-energy
wartime extremity injuries: prevalence and risk factors. J. Bone Joint Surg. Am. 91,
1084–1091.
Forsberg, J.A., Potter, B.K., Polfer, E.M., Safford, S.D., Elster, E.A., 2014. Do inﬂammatory
markers portend heterotopic ossiﬁcation and wound failure in combat wounds?
Clin. Orthop. Relat. Res. 472, 2845–2854.
Gillern, S.M., Sheppard, F.R., Evans, K.N., et al., 2011. Incidence of pulmonary embolus in
combat casualties with extremity amputations and fractures. J. Trauma 71, 607–613.
Gould, A.P., 1917. An Address ON MODERN ANTISEPTICS: Delivered at a Meeting of the
Hunterian Society on November 7th, 1917. Br. Med. J. 2, 677–679.
Hawksworth, J.S., Stojadinovic, A., Gage, F.A., et al., 2009. Inﬂammatory biomarkers in
combat wound healing. Ann. Surg. 250, 1002–1007.
Ho, T.K., 1998. The random subspace method for constructing decision forests. IEEE Trans.
Pattern Anal. Mach. Intell. 20, 832–844.
Hostetler, S.G., Xiang, H., Gupta, S., 2006. Discharge patterns of injury-related
hospitalizations with an acute wound in the United States. Wounds 18, 340–351.
Krell, K.E., 2010. Critical care medicine growth requires dealing with our ‘perfect storm’ of
manpower shortage. Crit. Care Med. 38, 1613–1614.
Krizek, T.J., Robson, M.C., 1975. Evolution of quantitative bacteriology in wound manage-
ment. Am. J. Surg. 130, 579–584.
Lakstein, D., Blumenfeld, A., Sokolov, T., et al., 2003. Tourniquets for hemorrhage control
on the battleﬁeld: a 4-year accumulated experience. J. Trauma 54, S221–S225.
Landrum, M.L., Murray, C.K., 2008. Ventilator associated pneumonia in a military
deployed setting: the impact of an aggressive infection control program. J. Trauma
64, S123–S128.
Larrey, B.D.J., 1814. Memoirs of Military Surgery, and Campaigns of the French Armies, on
the Rhine, in Corsica, Catalonia, Egypt, and Syria; at Boulogne, Ulm, and Austerlitz; in
Saxony, Prussia, Poland, Spain, and Austria.
Liedberg, N.C.F., Reiss, E., Artz, C.P., 1955. The effects of bacteria on the take of
split-thickness skin grafts in rabbits. Plast. Reconstr. Surg. 16, 412.
Livak, K.J., Schmittgen, T.D., 2001. Analysis of relative gene expression data using real-
time quantitative PCR and the 2−ΔΔCT method. Methods 25, 402–408.
Meleney, F.L., 1948. The prevention of infection in accidental wounds. In: Andrus, E.C.,
Bronk, D.W., Carden, G.A., et al. (Eds.), Advances in Military Medicine. Little, Brown
& Co, Boston, MA, pp. 95–110.
Moorhead, J.J., 1942a. Surgical experience at Pearl Harbor. JAMA 118, 712–714.
Moorhead, J.J., 1942b. War wounds. In: Pugh, W.S., Podolsky, E., Runes, D.D. (Eds.), War
Surgery. Philosophical Library, New York, NY, pp. 24–26.
Neushul, P., 1993. Science, government and the mass production of penicillin. J. Hist. Med.
Allied Sci. 48, 371–395.
Nisbet, R., Elder IV, J., Miner, G., 2009. Model evaluation and enhancement. Handbook of
Statistical Analysis Data Mining Applications. Academic Press, pp. 285–311.
Potter, B.K., Burns, T.C., Lacap, A.P., Granville, R.R., Gajewski, D.A., 2007. Heterotopic
ossiﬁcation following traumatic and combat-related amputations. Prevalence, risk
factors, and preliminary results of excision. J. Bone Joint Surg. Am. 89, 476–486.
R Core Team, d. R: A language and environment for statistical computinghttp://www.R-
project.org/.
Rich, N.M., Hughes, C.W., 1969. Vietnam vascular registry: a preliminary report. Surgery
65, 218–226.
Robson, M.C., Heggers, J.P., 1969. Bacterial quantiﬁcation of open wounds. Mil. Med. 134,
19–24.
Selcer, P., 2008. Standardizing wounds: Alexis Carrel and the scientiﬁc management of life
in the First World War. Br. J. Hist. Sci. 41, 73–107.
Sherertz, R.J., Garibaldi, R.A., Marosok, R.D., 1992. Consensus paper on the surveillance of
surgical wound infections. Am. J. Infect. Control 263–270.
Sheridan, R.L., Shumaker, P.R., King, D.R., Wright, C.D., Itani, K.M.F., Cancio, L.C., 2014. Case
records of the Massachusetts General Hospital. Case 15-2014. A man in the military
who was injured by an improvised explosive device in Afghanistan. N. Engl. J. Med.
370, 1931–1940.
Stromeyer, L., 1862. Gunshot fractures. Resection in Gunshot Injuries. J.B. Lippincott & Co,
Philadelphia, pp. 20–32.
Tibshirani, R., 1997. The lasso method for variable selection in the Cox model. Stat. Med.
16, 385–395.
Vandesompele, J., De Preter, K., Pattyn, F., et al., 2002. Accurate normalization of real-time
quantitative RT-PCR data by geometric averaging of multiple internal control genes.
Genome Biol. 3 (RESEARCH0034).
Vickers, A.J., Elkin, E.B., 2006. Decision curve analysis: a novel method for evaluating
prediction models. Med. Decis. Mak. 26, 565–574.
Warkentien, T., Rodriguez, C., Lloyd, B., et al., 2012. Invasive mold infections following
combat-related injuries. Clin. Infect. Dis. 55, 1441–1449.
